BrainNeurosciencePeer-reviewed journal article
Cognitive and GABAergic protection by hAPPSw,Ind and hTauVLW coexpression: a model of Non-Demented with Alzheimer's disease Neuropathology
Eva Dávila-BouziguetiD, Arnau Casòliba-MelichiD, Georgina Targa Fabra, Lorena Galera-LópeziD, Andrés OzaitaiD, Rafael J. MaldonadoiD, Jesús ÁvilaiD, Jose Maria Delgado-GarciaiD, Agnès GruartiD, Eduardo SorianoiD, Marta PascualiD
Abstract
Alzheimers disease comprises amyloid-{beta} (A{beta}) and hyperphosphorylated Tau (P-Tau) accumulation, imbalanced neuronal activity, aberrant oscillatory rhythms, and cognitive deficits. Non-Demented with Alzheimers disease Neuropathology (NDAN) defines a novel clinical entity with A{beta} and Tau pathologies, but preserved cognition. The mechanisms underlying such neuroprotection remain undetermined and animal models are currently unavailable for NDAN. We show that J20/VLW mice, accumulating A{beta} and P-Tau, exhibit preserved hippocampal rhythmic activity and cognition, altered in J20 and VLW animals. Furthermore, we show that coexistence with A{beta} renders a particular P-Tau signature in hippocampal interneurons. The GABAergic septohippocampal pathway, responsible for hippocampal rhythmic activity, is preserved in J20/VLW mice, in contrast to single mutants. Our data highlight J20/VLW mice as a suitable animal model to understand the mechanisms driving cognitive preservation in NDAN and suggest that a differential P-Tau pattern in hippocampal interneurons prevents GABAergic septohippocampal innervation loss and alterations in local field potentials, avoiding cognitive deficits.
- Citations
- 4
- FWCI
- 0.31
- Field percentile
- top 45%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Co-activation of selective nicotinic acetylcholine receptor subtypes is required for neuroprotection against Alzheimers disease
Rahmi Lee, Gayeon Kim, … Seonil Kim·Advanced SciencePeer-reviewed·Sep 27, 2026
- The Time Course of Recognition Memory Impairment and Glial Pathology in the hApp-J20 Mouse Model of Alzheimer’s Disease
Kamar E. Ameen‐Ali, Julie E. Simpson, … Jason Berwick·Journal of Alzheimer s DiseasePeer-reviewed·Feb 19, 2019
- Alterations to parvalbumin-expressing interneuron function and associated network oscillations in the hippocampal - medial prefrontal cortex circuit during natural sleep in APPNL-G-F mice
Erica S Brady, Jessica Griffiths, … Michael T. Craig·Neurobiology of DiseasePeer-reviewed·May 10, 2023
- Chemogenetic activation of midline thalamic nuclei fails to ameliorate memory deficits in two mouse models of Alzheimer's disease
Shivali Kohli, Lilya Andrianova, … Michael T. Craig·bioRxiv·Jun 30, 2021
- Manipulation of neuronal activity in the entorhinal-hippocampal circuit affects intraneuronal amyloid-β levels
Christiana Bjorkli, Nora Cecilie Ebbesen, … Ioanna Sandvig·bioRxiv·Jul 5, 2022
- Astrocyte-neuron interplay is critical for Alzheimer's disease pathogenesis and is rescued by TRPA1 channel blockade
Adrien Paumier, Sylvie Boisseau, … Mireille Albrieux·BrainPeer-reviewed·Jul 22, 2021